Medpace is a full-service contract research organization (CRO) founded in 1992 and headquartered in Cincinnati, USA. The company has operated for more than three decades and has expanded through organic growth, without mergers and acquisitions - an approach it says preserves team continuity and avoids M&A-related operational disruption. For candidates evaluating a long-term employer, the pattern is one of steady expansion rather than periodic integration.
The firm advances clinical research through an outsourced, scientifically driven model, accelerating global development of safe and effective medical therapeutics for biotechnology, pharmaceutical and medical-device sponsors. Its technical domains cover clinical research outsourcing, clinical trial management, bioanalytical and central laboratory services, a medical imaging core laboratory, a cardiac safety core laboratory, Phase I clinical trials, regulatory affairs and patient recruitment.
Operational capability is anchored in a set of dedicated service units: integrated Central and Bioanalytical Laboratories, an Imaging Core Laboratory for trial endpoint assessment, a Cardiac Safety Core Laboratory, a Phase I Unit for early-phase studies, and a Clinical Trial Management System (CTMS) used to run trials. Medpace combines local expertise with global resources across North America, Europe, Latin America and Asia Pacific.
The company describes itself as an extension of its clients' teams, with an emphasis on therapeutic, regulatory and operational expertise and on making complex clinical development seamless.
